review Open AccessTop 1% cited

Nicotine replacement therapy for smoking cessation

Cochrane Database of Systematic Reviews · 2012 · Vol. 11 · pp. CD000146–CD000146

Lindsay F Stead✉(University of Oxford)Rafael Perera(University of Oxford)Chris Bullen(University of Auckland)David Mant(University of Oxford)Jamie Hartmann‐Boyce(University of Oxford)Kate Cahill(University of Oxford)Tim Lancaster(University of Oxford)

View via DOI Full-text PDF

Abstract

All of the commercially available forms of NRT (gum, transdermal patch, nasal spray, inhaler and sublingual tablets/lozenges) can help people who make a quit attempt to increase their chances of successfully stopping smoking. NRTs increase the rate of quitting by 50 to 70%, regardless of setting. The effectiveness of NRT appears to be largely independent of the intensity of additional support provided to the individual. Provision of more intense levels of support, although beneficial in facilitating the likelihood of quitting, is not essential to the success of NRT.

Smoking Behavior and Cessation Nicotinic Acetylcholine Receptors Study Asthma and respiratory diseasesNicotine replacement therapyMedicineSmoking cessationAbstinencePlaceboNicotineNicotine gumAddictionRandomized controlled trialNicotine patch

MeSH terms

Smoking PreventionAdministration, CutaneousAdministration, InhalationChewing GumHumansNicotineTabletsRandomized Controlled Trials as TopicSmoking CessationNicotinic AgonistsTobacco Use Cessation Devices

Citations

2,480

FWCI

113.50

field-weighted impact

References

475

Percentile

100%

vs. same field & year

Citations per year

Cited by